Markus Britschgi, Ph.D.

Affiliations: 
Roche, Indianapolis, IN, United States 
Area:
Neuroimmunology, neurodegeneration, aging
Google:
"Markus Britschgi"
Mean distance: 16.16 (cluster 32)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Czirr E, Castello NA, Mosher KI, et al. (2017) Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity. The Journal of Experimental Medicine
Jaeger PA, Lucin KM, Britschgi M, et al. (2016) Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain. Molecular Neurodegeneration. 11: 42
Jaeger PA, Lucin KM, Britschgi M, et al. (2016) Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain. Molecular Neurodegeneration. 11: 31
Lehallier B, Essioux L, Gayan J, et al. (2015) Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease. Jama Neurology. 1-10
Knuesel I, Chicha L, Britschgi M, et al. (2014) Maternal immune activation and abnormal brain development across CNS disorders. Nature Reviews. Neurology. 10: 643-60
Grathwohl SA, Steiner JA, Britschgi M, et al. (2013) Mind the gut: secretion of α-synuclein by enteric neurons. Journal of Neurochemistry. 125: 487-90
Luo J, Elwood F, Britschgi M, et al. (2013) Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. The Journal of Experimental Medicine. 210: 157-72
Lema Tomé CM, Tyson T, Rey NL, et al. (2013) Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link? Molecular Neurobiology. 47: 561-74
Toovey S, Prinssen EP, Rayner CR, et al. (2012) Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review. Advances in Therapy. 29: 826-48
Britschgi M, Takeda-Uchimura Y, Rockenstein E, et al. (2012) Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice. Journal of Neuroinflammation. 9: 220
See more...